Showing 1 - 4 results of 4 for search 'A. G. Moiseenok', query time: 0.03s Refine Results
  1. 1
    ЛАБОРАТОРИЯ КЛИНИЧЕСКОЙ БИОХИМИИ КАФЕДРЫ ГОСПИТАЛЬНОЙ ТЕРАПИИ ГРОДНЕНСКОГО ГОСУДАРСТВЕННОГО МЕДИЦИНСКОГО ИНСТИТУТА – МЕЖВЕДОМСТВЕННЫЙ И МЕЖКАФЕДРАЛЬНЫЙ ОПЫТ ПЛОДОТВОРНОГО СОТРУДНИЧЕСТВА

    ЛАБОРАТОРИЯ КЛИНИЧЕСКОЙ БИОХИМИИ КАФЕДРЫ ГОСПИТАЛЬНОЙ ТЕРАПИИ ГРОДНЕНСКОГО ГОСУДАРСТВЕННОГО МЕДИЦИНСКОГО ИНСТИТУТА – МЕЖВЕДОМСТВЕННЫЙ И МЕЖКАФЕДРАЛЬНЫЙ ОПЫТ ПЛОДОТВОРНОГО СОТРУДНИЧ... by A. G. Moiseenok

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Antioxidant status and glutathione redox potential of erythrocytes in patients with acute coronary syndrome

    Antioxidant status and glutathione redox potential of erythrocytes in patients with acute coronary syndrome by I. V. Buko, L. Z. Polonetsky, A. G. Mrochek, A. G. Moiseenok

    Published 2014-06-01
    Get full text
    Article
  3. 3
    Antioxidants selenomethionine and D-pantethine differentially affect doxorubicin’s action on glutathione system in human leukemia cells varying in their resistance to chemotherapy in vitro

    Antioxidants selenomethionine and D-pantethine differentially affect doxorubicin’s action on glutathione system in human leukemia cells varying in their resistance to chemotherapy... by Yu. S. Kozak, R. R. Panchuk, N. R. Skorokhyd, D. S. Semenovich, A. G. Moiseenok, R. S. Stoika

    Published 2018-09-01
    Get full text
    Article
  4. 4
    Selenium-containing compounds and D-panthetine modulate the action of doxorubicin and cisplatin towards drug-resistant tumor cells

    Selenium-containing compounds and D-panthetine modulate the action of doxorubicin and cisplatin towards drug-resistant tumor cells by R. R. Panchuk, N. R. Skorokhyd, V. V. Chumak, L. V. Lehka, A. G. Moiseenok, W. Berger, R. S. Stoika

    Published 2013-12-01
    Get full text
    Article

Search Tools: